Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Convergent eusocial evolution is based on a shared reproductive groundplan plus lineage-specific plastic genes.

Warner MR, Qiu L, Holmes MJ, Mikheyev AS, Linksvayer TA.

Nat Commun. 2019 Jun 14;10(1):2651. doi: 10.1038/s41467-019-10546-w.

2.

Transcriptomic basis and evolution of the ant nurse-larval social interactome.

Warner MR, Mikheyev AS, Linksvayer TA.

PLoS Genet. 2019 May 20;15(5):e1008156. doi: 10.1371/journal.pgen.1008156. eCollection 2019 May.

3.

Genomic Signature of Kin Selection in an Ant with Obligately Sterile Workers.

Warner MR, Mikheyev AS, Linksvayer TA.

Mol Biol Evol. 2017 Jul 1;34(7):1780-1787. doi: 10.1093/molbev/msx123.

4.

Implementing Benefit-Risk Assessment for the Periodic Benefit-Risk Evaluation Report.

Warner MR, Wolka AM, Noel RA.

Ther Innov Regul Sci. 2016 May;50(3):342-346. doi: 10.1177/2168479015609650.

PMID:
30227065
5.

Does Teriparatide Improve Femoral Neck Fracture Healing: Results From A Randomized Placebo-controlled Trial.

Bhandari M, Jin L, See K, Burge R, Gilchrist N, Witvrouw R, Krohn KD, Warner MR, Ahmad QI, Mitlak B.

Clin Orthop Relat Res. 2016 May;474(5):1234-44. doi: 10.1007/s11999-015-4669-z. Epub 2016 Mar 1.

6.
7.

Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH.

Bone. 2010 Apr;46(4):935-9. doi: 10.1016/j.bone.2009.12.032. Epub 2010 Jan 6.

PMID:
20060081
8.

Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.

Eastell R, Chen P, Saag KG, Burshell AL, Wong M, Warner MR, Krege JH.

Bone. 2010 Apr;46(4):929-34. doi: 10.1016/j.bone.2009.12.021. Epub 2010 Jan 6.

PMID:
20060078
9.

Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.

Devogelaer JP, Adler RA, Recknor C, See K, Warner MR, Wong M, Krohn K.

J Rheumatol. 2010 Jan;37(1):141-8. doi: 10.3899/jrheum.090411. Epub 2009 Nov 16.

PMID:
19918047
10.

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

Saag KG, Zanchetta JR, Devogelaer JP, Adler RA, Eastell R, See K, Krege JH, Krohn K, Warner MR.

Arthritis Rheum. 2009 Nov;60(11):3346-55. doi: 10.1002/art.24879.

11.

Patient experience with a new teriparatide delivery device.

Dore RK, Feldman RG, Taylor KA, See K, Dalsky GP, Warner MR.

Curr Med Res Opin. 2009 Oct;25(10):2413-22. doi: 10.1185/03007990903173074.

PMID:
19656016
12.

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status.

Langdahl BL, Marin F, Shane E, Dobnig H, Zanchetta JR, Maricic M, Krohn K, See K, Warner MR.

Osteoporos Int. 2009 Dec;20(12):2095-104. doi: 10.1007/s00198-009-0917-y. Epub 2009 Apr 7.

PMID:
19350340
13.

Active comparator trial of teriparatide vs alendronate for treating glucocorticoid-induced osteoporosis: results from the Hispanic and non-Hispanic cohorts.

Losada BR, Zanchetta JR, Zerbini C, Molina JF, De la Peña P, Liu CC, Smith RB, Nino AJ, Krohn K, Warner MR.

J Clin Densitom. 2009 Jan-Mar;12(1):63-70. doi: 10.1016/j.jocd.2008.10.002. Epub 2008 Nov 22.

PMID:
19028124
14.

Comparison of speed of onset of platelet inhibition after loading doses of clopidogrel versus prasugrel in healthy volunteers and correlation with responder status.

Weerakkody GJ, Jakubowski JA, Brandt JT, Farid NA, Payne CD, Zhu J, Warner MR, Naganuma H, Winters KJ.

Am J Cardiol. 2007 Jul 15;100(2):331-6. Epub 2007 May 25.

PMID:
17631093
15.

Environmental noise alters gastric myoelectrical activity: Effect of age.

Castle JS, Xing JH, Warner MR, Korsten MA.

World J Gastroenterol. 2007 Jan 21;13(3):403-7.

16.

Effects of tadalafil on myocardial blood flow in patients with coronary artery disease.

Weinsaft JW, Hickey K, Bokhari S, Shahzad A, Bedding A, Costigan TM, Warner MR, Emmick JT, Bergmann SR.

Coron Artery Dis. 2006 Sep;17(6):493-9.

PMID:
16905960
17.

Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study.

Dean J, Hackett GI, Gentile V, Pirozzi-Farina F, Rosen RC, Zhao Y, Warner MR, Beardsworth A.

J Sex Med. 2006 Jul;3(4):650-661. doi: 10.1111/j.1743-6109.2006.00261.x.

PMID:
16839321
18.

Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing.

Kloner RA, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner MR, Costigan TM, Vail GM.

Am J Cardiol. 2006 Jun 15;97(12):1778-84. Epub 2006 Apr 27.

PMID:
16765134
19.

Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events.

Jackson G, Kloner RA, Costigan TM, Warner MR, Emmick JT.

J Sex Med. 2004 Sep;1(2):161-7.

PMID:
16422970
20.
21.

Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice.

Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA.

J Immunol. 2005 Sep 1;175(5):3053-9.

22.

The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval.

Beasley CM Jr, Mitchell MI, Dmitrienko AA, Emmick JT, Shen W, Costigan TM, Bedding AW, Turik MA, Bakhtyari A, Warner MR, Ruskin JN, Cantilena LR Jr, Kloner RA.

J Am Coll Cardiol. 2005 Aug 16;46(4):678-87.

23.

Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men.

Kloner RA, Jackson G, Emmick JT, Mitchell MI, Bedding A, Warner MR, Pereira A.

J Urol. 2004 Nov;172(5 Pt 1):1935-40.

PMID:
15540759
24.

Pattern formation in thin liquid films with charged surfactants.

Warner MR, Craster RV, Matar OK.

J Colloid Interface Sci. 2003 Dec 15;268(2):448-63.

PMID:
14643247
25.

Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.

Masteller EL, Warner MR, Ferlin W, Judkowski V, Wilson D, Glaichenhaus N, Bluestone JA.

J Immunol. 2003 Nov 15;171(10):5587-95.

26.

Surface patterning via evaporation of ultrathin films containing nanoparticles.

Warner MR, Craster RV, Matar OK.

J Colloid Interface Sci. 2003 Nov 1;267(1):92-110.

PMID:
14554172
27.

Schwannoma of the vagus nerve first diagnosed as a parotid tumor.

Cunningham LL Jr, Warner MR.

J Oral Maxillofac Surg. 2003 Jan;61(1):141-4. No abstract available.

PMID:
12524624
28.
29.

Sinus slot technique for simplification and improved orientation of zygomaticus dental implants: a technical note.

Stella JP, Warner MR.

Int J Oral Maxillofac Implants. 2000 Nov-Dec;15(6):889-93.

PMID:
11151591
30.

Lupus erythematosus associated with erythema multiforme: does Rowell's syndrome exist?

Shteyngarts AR, Warner MR, Camisa C.

J Am Acad Dermatol. 1999 May;40(5 Pt 1):773-7. Review.

PMID:
10321612
31.

Allergic contact dermatitis from transdermal clonidine in a patient with mycosis fungoides.

Polster AM, Warner MR, Camisa C.

Cutis. 1999 Mar;63(3):154-5.

PMID:
10190065
32.

Agents causing contact urticaria.

Warner MR, Taylor JS, Leow YH.

Clin Dermatol. 1997 Jul-Aug;15(4):623-35. Review. No abstract available.

PMID:
9255474
33.

Functional evaluation of gap vs. abutment repair of peripheral nerves in the rat.

Weber RA, Warner MR, Verheyden CN, Proctor WH.

J Reconstr Microsurg. 1996 Apr;12(3):159-63.

PMID:
8726335
34.

In vivo and in vitro electrophysiologic effects of terodiline on dog myocardium.

Pressler ML, Warner MR, Rubart M, Rardon DP, Zipes DP.

J Cardiovasc Electrophysiol. 1995 Jun;6(6):443-54.

PMID:
7551314
35.
36.

Mechanisms of denervation supersensitivity in regionally denervated canine hearts.

Warner MR, Wisler PL, Hodges TD, Watanabe AM, Zipes DP.

Am J Physiol. 1993 Mar;264(3 Pt 2):H815-20.

PMID:
8384424
37.

Simulated ischemia does not protect against efferent sympathetic denervation following acute myocardial infarction in canine hearts.

Rubart M, Pride HP, Kroeker TS, Warner MR, Zipes DP.

J Cardiovasc Electrophysiol. 1993 Feb;4(1):23-37.

PMID:
8287234
38.

Autotomy and the sciatic functional index.

Weber RA, Proctor WH, Warner MR, Verheyden CN.

Microsurgery. 1993;14(5):323-7.

PMID:
8332052
39.
40.

Circulating neuropeptide Y in dog plasma consists of multiple peptide fragments.

deS Senanayake P, Warner MR, Brosnihan KB, Levy MN, Ferrario CM.

Peptides. 1992 Nov-Dec;13(6):1165-73.

PMID:
1283629
41.

Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart.

Warner MR, Senanayake PD, Ferrario CM, Levy MN.

Circ Res. 1991 Aug;69(2):455-65.

PMID:
1776971
42.
43.
44.

Neuropeptide Y as a putative modulator of the vagal effects on heart rate.

Warner MR, Levy MN.

Circ Res. 1989 May;64(5):882-9.

PMID:
2706760
45.

Phasic influences of vagal stimulation on atrioventricular conduction.

Warner MR, Loeb JM.

Can J Physiol Pharmacol. 1988 Sep;66(9):1198-205.

PMID:
3219664
46.

Postpacing tachycardia: autonomic involvement.

Loeb JM, deTarnowsky JM, Warner MR, Whitson CC.

Am J Physiol. 1987 Aug;253(2 Pt 2):H333-40.

PMID:
3618808
47.

Reflex regulation of atrioventricular conduction.

Warner MR, Loeb JM.

Am J Physiol. 1987 Jun;252(6 Pt 2):H1077-85.

PMID:
3109256
48.

Atrioventricular nodal accommodation: rate- and time-dependent effects.

Loeb JM, deTarnowsky JM, Whitson CC, Warner MR.

Am J Physiol. 1987 Mar;252(3 Pt 2):H578-84.

PMID:
3826402
49.

Beat-by-beat modulation of AV conduction. II. Autonomic neural mechanisms.

Warner MR, deTarnowsky JM, Whitson CC, Loeb JM.

Am J Physiol. 1986 Dec;251(6 Pt 2):H1134-42.

PMID:
3789166
50.

Beat-by-beat modulation of AV conduction. I. Heart rate and respiratory influences.

Warner MR, Loeb JM.

Am J Physiol. 1986 Dec;251(6 Pt 2):H1126-33.

PMID:
3789165

Supplemental Content

Loading ...
Support Center